Paroxetine increases heart rate variability in panic disorder

Journal of Clinical Psychopharmacology

Volumn 17, Issue 5, 1997, Pages 370-376

  Tucker, Phebe ^a,d   Adamson, Philip ^a,b   Miranda Jr , Robert ^c   Scarborough, Alfretia ^a   Williams, Dottie ^a   Groff, Jodie ^a   McLean, Heather ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART RATE VARIABILITY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PANIC; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AROUSAL; BAROREFLEX; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PANIC DISORDER; PARASYMPATHETIC NERVOUS SYSTEM; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 0030821584     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199710000-00006     Document Type: Article

References (26)

1. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990;147:1504-8.
2. Kahn JP, Drusin RE, Kline DF. Idiopathic cardiomyopathy and panic disorder clinical association in cardiac transplant candidates. Am J Psychiatry 1987;144:1327-30.
3. Coryell W, Noyes R, House JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry 1986;143:508-10.
4. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89: 1992-7.
5. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ 1987;295:297-9.
6. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. Circulation 1994;90: 2225-9.
7. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res 1991;37:35-46.
8. Yeragani VK, Pohl R, Balon R, Jung I, Kareus R. Heart rate in panic disorder [letter]. Acta Psychiatr Scand 1991;83:79.
9. Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, Srinivasan K, Weinberg P. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1992;46:89-103.
10. Tucker P, Adamson P, Corbin B, Williams D, Groff J, Bottoms M. Heart rate variability in panic patients: autonomie balance. Abstract and poster presentation, annual meeting of American Psychiatric Association, San Francisco, CA, 1994.
11. Friedman BH, Thayer JF, Borkovec TD, Tyrrell RA, Johnson BH, Columbo R. Autonomie characteristics of nonclinical panic and blood phobia. Biol Psychiatry 1993;34:298-310.
12. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990;51[suppl]:4-9.
13. Dreifus LS, Agarwal JB, Botvinick EH, Ferdinand KC, Fisch C, Fisher JD, Kennedy JW, Kerber RE, Lambert CR, Okike ON, Prystowsky N, Saksena SV, Schroeder JS, Williams DO. Heart rate variability for risk stratification of life-threatening arrhythmias. J Am Coll Cardiol 1993;22:948-50.
14. Van Ravenswaaij-Arts CMA, Kollee LAA, Hopman JCW, Stoelinga GBA, van Geijn HP. Heart rate variability. Ann Intern Med 1993; 118:436-47.
15. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Weinberg P, Merlos B. Effect of imipramine treatment on heart rate variability measures. Biol Psychiatry 1992;26:27-32.
16. Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability, J Clin Psychopharmacology 1994;14:392-395.
17. Yeragani V, Sobolewski E, Johnson C, Kay J, Jampala VC, Hillman N, Igel G. Effect of paroxetine on heart rate variability in panic disorder: analysis of Holter records [abstract]. Biol Psychiatry 1996;39:522.
18. Vanoli E, Adamson PB, Lin B, Pinna GD, Lazzara R, Orr WC. Heart rate variability during specific sleep stages: a comparison of healthy subjects with patients after myocardial infarction. Circulation 1995;91:1918-22.
19. Shields RW. Functional anatomy of the autonomic nervous system, J Clin Neurophysiol 1993;10:2-13.
20. de Ferrari GM, Vanoli E, Schwartz PJ. Cardiac vagal activity, myocardial ischemia and sudden death. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. Philadelphia: W.B. Saunders, 1995:422-34.
21. DeFarrari GM, Vanoli E, Curcuruto P, Tommasini G, Schwartz PJ. Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Am Heart J 1992;124:883-90.
22. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991;68:1471-81.
23. Billman GE, Schwartz PJ, Stone HL. The effects of daily exercise on susceptibility to sudden cardiac death. Circulation 1984;69: 1182-9.
24. Hull SS, Vanoli E, Adamson PB, De Ferrari GM, Foreman RD, Schwartz PJ. Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 1995;91:2516-9.
25. Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993;32:792-7.
26. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability - standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.